Compare Domino's Pizza, Inc. (DPZ) vs Oruka Therapeutics Inc. Common Stock (ORKA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Domino's Pizza, Inc. vs Oruka Therapeutics Inc. Common Stock — how do they compare? Domino's Pizza, Inc. trades at $296.58 (market cap $9.73B), while Oruka Therapeutics Inc. Common Stock trades at $76.8 (market cap $5.08B). The key difference: Domino's Pizza, Inc. is the larger of the two by market cap, and Domino's Pizza, Inc. pays a 2.69% dividend while Oruka Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Domino's Pizza, Inc. for 106 Days and Oruka Therapeutics Inc. Common Stock for 0 Days on average.
| DPZ | ORKA | |
|---|---|---|
Market Cap | $9.73B | $5.08B |
Volume | 1,426,037 | 685,276 |
Sector | Consumer Cyclical | Health |
52-Week High | $438.42 | $113.08 |
52-Week Low | $282.89 | $26.19 |
Typical Hold Time | 106 Days | 0 Days |
Enterprise Value | $14.63B | $4.21B |
Dividend Yield | 2.69% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Domino's Pizza (DPZ) trades at $296.10, down 4.76% with recent earnings showing mixed results including a Q3 2026 beat. The stock maintains strong profitability with 12.03% net margin and trades at reasonable valuations (P/E 16.3, P/S 1.96). Technical indicators show a bullish overall signal despite near-term bearish pressure, with key support at $297. Recent news highlights dividend stability amid high debt levels and store closures in certain markets.
DPZ presents a compelling value opportunity with analyst consensus target of $361.44 (22% upside), though significant debt load and recent earnings misses warrant caution. The company's consistent revenue growth and strong cash flow generation support dividend sustainability, but competitive pressures and execution risks remain key watchpoints for investors.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Domino's Pizza, Inc.
Domino's is a restaurant operator and franchiser with nearly 19,000 global stores across more than 90 international markets at the end of 2021. The firm generates revenue through the sales of pizza, wings, salads, and sandwiches at company-owned stores, royalty and marketing contributions from franchise-operated stores, and its network of 25 domestic (and five Canadian) dough manufacturing and supply chain facilities, which centralize purchasing, preparation, and last-mile delivery for the firm's U.S. and Canadian restaurants. With roughly $17.7 billion in 2021 system sales, Domino's is the largest player in the global pizza market, ahead of Pizza Hut, Papa John's, and Little Caesars.
Read more on DPZ →About Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.
Read more on ORKA →
